Toby C. Trujillo

1.2k total citations
62 papers, 853 citations indexed

About

Toby C. Trujillo is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Toby C. Trujillo has authored 62 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 32 papers in Internal Medicine and 14 papers in Surgery. Recurrent topics in Toby C. Trujillo's work include Venous Thromboembolism Diagnosis and Management (32 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Acute Myocardial Infarction Research (10 papers). Toby C. Trujillo is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (32 papers), Atrial Fibrillation Management and Outcomes (24 papers) and Acute Myocardial Infarction Research (10 papers). Toby C. Trujillo collaborates with scholars based in United States, Australia and Belgium. Toby C. Trujillo's co-authors include Paul P. Dobesh, Paul E. Nolan, Tyree H. Kiser, Stuart E. Lind, Sheila Fisher, Shannon W. Finks, Kathryn L. Hassell, Zachary A. Stacy, Kristen E. Nordenholz and Scott W. Mueller and has published in prestigious journals such as Critical Care Medicine, Pharmacology & Therapeutics and Drugs.

In The Last Decade

Toby C. Trujillo

59 papers receiving 823 citations

Peers

Toby C. Trujillo
Steven P. Dunn United States
Heng Joo Ng Singapore
Tania Ahuja United States
Stacy A. Voils United States
Jeffrey D. Wessler United States
Brian G. Katona United States
Steven P. Dunn United States
Toby C. Trujillo
Citations per year, relative to Toby C. Trujillo Toby C. Trujillo (= 1×) peers Steven P. Dunn

Countries citing papers authored by Toby C. Trujillo

Since Specialization
Citations

This map shows the geographic impact of Toby C. Trujillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby C. Trujillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby C. Trujillo more than expected).

Fields of papers citing papers by Toby C. Trujillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby C. Trujillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby C. Trujillo. The network helps show where Toby C. Trujillo may publish in the future.

Co-authorship network of co-authors of Toby C. Trujillo

This figure shows the co-authorship network connecting the top 25 collaborators of Toby C. Trujillo. A scholar is included among the top collaborators of Toby C. Trujillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby C. Trujillo. Toby C. Trujillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Alexandre, William L. Baker, Daniel Abazia, et al.. (2025). Impact of artificial intelligence on future clinical pharmacy research and scholarship. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(4). 311–316. 2 indexed citations
2.
Trujillo, Toby C., et al.. (2025). Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients. Clinical and Applied Thrombosis/Hemostasis. 31. 3015501465–3015501465.
3.
Castelino, Ronald L., et al.. (2025). Ethical interventions: revisiting the assessment tools for health-system pharmacists. Frontiers in Medicine. 12. 1536044–1536044.
4.
Dager, William E., Toby C. Trujillo, & Brian W. Gilbert. (2023). Approaches to Precision‐based Anticoagulation management in the critically Ill. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(11). 1221–1236. 3 indexed citations
6.
Beavers, Craig J., Robert J. DiDomenico, Steven P. Dunn, et al.. (2021). Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(11). 932–942. 24 indexed citations
7.
Trujillo, Toby C., et al.. (2021). Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19. Journal of Thrombosis and Thrombolysis. 53(2). 446–453. 5 indexed citations
8.
Case, David, et al.. (2020). A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis. Annals of Pharmacotherapy. 55(3). 286–293. 20 indexed citations
9.
Trujillo, Toby C., et al.. (2020). Evaluation of Medication Administration Timing—Are We Meeting Our Goals?. Journal of Pharmacy Practice. 34(5). 750–754. 5 indexed citations
10.
Dobesh, Paul P., Shannon W. Finks, & Toby C. Trujillo. (2020). Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events. Clinical Therapeutics. 42(10). 2084–2097. 4 indexed citations
11.
Trujillo, Toby C., et al.. (2020). Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal. The American Journal of Emergency Medicine. 38(10). 2096–2100. 9 indexed citations
12.
Dobesh, Paul P., et al.. (2019). Antidotes for reversal of direct oral anticoagulants. Pharmacology & Therapeutics. 204. 107405–107405. 10 indexed citations
13.
Trujillo, Toby C., et al.. (2019). Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center. Clinical and Applied Thrombosis/Hemostasis. 25. 2873295147–2873295147. 21 indexed citations
14.
Trujillo, Toby C., Paul P. Dobesh, George H. Crossley, & Shannon W. Finks. (2018). Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(1). 94–108. 1 indexed citations
15.
Trujillo, Jennifer, et al.. (2016). The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. American Journal of Pharmaceutical Education. 80(10). 174–174. 12 indexed citations
16.
Trujillo, Toby C., et al.. (2014). The role of prothrombin complex concentrates in reversal of target specific anticoagulants. Thrombosis Journal. 12(1). 8–8. 35 indexed citations
17.
Kiser, Tyree H., et al.. (2010). Evaluation of empiric versus nomogram‐based direct thrombin inhibitor management in patients with suspected heparin‐induced thrombocytopenia. American Journal of Hematology. 86(3). 267–272. 24 indexed citations
18.
Dobesh, Paul P., Ann K. Wittkowsky, Zachary A. Stacy, et al.. (2009). Key Articles and Guidelines in the Treatment of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(11). 1385–1385. 10 indexed citations
19.
Trujillo, Toby C. & Paul P. Dobesh. (2007). Traditional Management of Chronic Stable Angina. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1677–1691. 10 indexed citations
20.
Trujillo, Toby C. & Paul E. Nolan. (2000). Antiarrhythmic Agents. Drug Safety. 23(6). 509–532. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026